Connecticut SB 439: AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW AND STEM CELL TRANSPLANTS AND FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

Status: REF. TO JOINT COMM. ON Human Services (as of 2025-01-10)

State: Connecticut · Session: 2025 · Bill: SB 439

Subjects: Health insurance, Medicaid, Sickle cell disease, Stem cell research

View Connecticut SB 439 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.